Process for the manufacture of (+)-(s)-clopidogrel bisulfate form-1
US7291735B2 · kind B2 · utility
5Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2003 |
| Grant date | Nov 6, 2007 |
| Priority date | — |
| Expiry date | Aug 15, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel process for the manufacture of blood-platelet aggregation inhibiting agent. In particular, the present invention is directed to a process for the manufacture of Methyl-(+)-(S)-α-(2-chlorophenyl)-6,7-dihydrothieno [3,2-c]pyridine-S-(4H)acetate bisulfate Form-I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.